Views & Analysis | Perspectives on pharma industry issues

R&D

Empty waiting room chairs for clinical trial enrolment

When metrics measure more than they improve

The question to ask is not, "Are we measuring site performance?" but, "Are the metrics we collect providing actionable insights early enough?"

Market Access

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Sales & Marketing

Recruitment concept graphic on beige background

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.

Patients

Physical performance × nutrition — a multiplicative relation...

Physical performance and nutrition are not just complementary, but biologically multiplicative.

Views & Analysis

R&D Roundup: Pharma gets in on the biotech boom

Some good news for the UK industry in turbulent times is always welcome, and several announcement this month showed us why the biotech sector in the country is looking extremely promising g

R&D

The patient perspective on advocacy

Growing up with the shadow of Huntington’s disease (HD) means Seth Rotberg understands the importance of peer support and credible information.

Views & Analysis

Harnessing RWE in rare diseases

Ahead of eyeforpharma Philadelphia 2019, Sonal Bhatia, Pfizer’s vice president, North America medical lead, rare disease talked to us about the importance of collaboration and RWE to he

Sales & Marketing

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Sales & Marketing

Personalisation is the biggest lie brands keep telling

Pharma brands need to move beyond surface-level personalisation and focus on measurable impact.

Digital

Technology solutions for smarter clinical trials: Inventus

In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos

Digital

Changing Faces: Digital and supplier hires, June and July 20...

The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July.

Market Access

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.